ClinicalTrials.gg
Not yet recruitingNCT07863375Updated Oct 15, 2026

Nurse-Delivered Brief Pain Relief Skills Treatment in Rural Communities

An interventional study of Pain relief skills training and Health Education in Chronic Pain, sponsored by Washington State University. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Washington State University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 15, 2026Eligibility revisedPrimary outcomes revised+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 1,283 studies in Chronic Pain with a site in United States — 257 open to participants now, 348 under way, 7 of them phase 3. Chronic Pain · United States.

Planned enrollment
84th of 1,092
400 · median 60
Started
2027
with 11 others
No phase
803 of 1,283
168 open now
Primary completion
2030-09
later than 337 of 347 live
Registered
1,277th of 1,283
by date

Among the 1,283 studies in Chronic Pain with a site in United States, this one is the 84th largest by planned enrollment of the 1,092 interventional ones that give a count, is one of 12 that started in 2027, is one of 803 with no phase, reaches primary completion later than 337 of the 347 other live ones, and was the 1,277th registered.

Chronic Pain

3,230 studies on the registry are indexed under Chronic Pain; 728 are open to participants now.

Browse Chronic Pain studies →

Open to participants now

257 of the 1,283 studies in Chronic Pain with a site in United States are open now. Recruiting first, the newest first:

252 more — sign in →

All 257 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 486 Chronic Pain studies recruiting now, 239 (49%) set no upper age limit and 173 (36%) stop at 75 or younger; 43 take children under 18; 64 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 1,283 studies in Chronic Pain with a site in United States, or all of them as a file.
02

Study summary

The goal of this randomized clinical trial is to learn if a nurse-delivered psychoeducational pain management skills intervention [Empowered Relief] can improve pain outcomes for adults with chronic pain who live in rural communities The main question[s] it aims to answer are:

Does nurse-delivered Empowered Relief improve pain intensity and pain interference more than a health education intervention after 3 months? Does nurse-delivered Empowered Relief improve pain catastrophizing, pain self-efficacy, and relaxation response more than a health education intervention after 3 months? Does nurse-delivered Empowered Relief improve sleep disturbance, depression, fatigue, and anxiety more than a health education intervention after 3 months?

Participants will:

Attend either a single-session 2-hour Empowered Relief class or a Health Education intervention.

Complete assessments measuring pain and related symptoms with online surveys immediately post-intervention and 3 months later.

Receive daily prompts to practice skills from the intervention.

Read the detailed description

This study will be conducted as a randomized controlled trial comparing effects of Empowered Relief (ER) to a Health Education (HE) session for participants with chronic pain recruited from rural clinics when ER is provided by ER-trained nurses. Participants (N=400) will complete an online eligibility form to screen for inclusion and exclusion criteria and advance to a consent process if eligible. Eight nurses recruited from rural communities will receive ER training facilitated by Stanford Pain Relief Innovations Lab. Recruitment will occur through three partnering rural health clinics. Study participants will be asked to complete a baseline survey of demographics and health variables and then randomized to one of two study groups: ER and HE. Participants randomized to the ER group will complete a Health Insurance Portability and Accountability Act [HIPAA] compliant, password protected Zoom ER class delivered by an ER-trained rural nurse instructor. Participants assigned to HE will receive a standardized online self-paced intervention.

03

Conditions studied

  • Chronic Pain

Keywords

  • Pain
04

Who can participate

The criteria were revised on the registry on Oct 15, 2026. See what changed

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≥18 years of age
  • Pain condition with duration ≥ 3 months
  • Capacity to give
  • Able to read, speak, and understand English
  • Past month average pain intensity score ≥ 4/10 on a 0-10 Numerical Rating Scale

Exclusion criteria

Exclusion Criteria:

  • Cognition found to be moderately or severely impaired on screening
  • Active suicidality (online screening)
  • Receipt of Empowered Relief or digital Health Education in the past 6 months
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
400 participants (estimated)

Study arms

  • Experimental
    Empowered Relief

    Participants randomized to the ER group will complete a HIPAA compliant, password protected 2-hour Zoom ER class delivered by an ER-trained registered nurse (RN).

    Behavioral: Pain relief skills training

  • Active comparator
    Health Education

    Participants randomized to the digital Health Education (HE) Control group will receive an educational intervention similar in time and attention to compare with the experimental treatment group.

    Other: Health Education

Interventions

  • BehavioralPain relief skills training

    Rural RN-delivered psychoeducational pain relief skills group intervention includes development of a personalized plan, downloading a corresponding app for daily and unlimited use, and daily text messages for 90 days..

  • OtherHealth Education

    A digital health education intervention is roughly matched for time, attention, and daily text for 90 days.

06

What researchers measure

Primary outcomes

  1. Pain intensity

    Patient-reported outcomes measures (PROMIS) Pain Intensity short form 1a to measure reported average pain intensity over the previous seven days using an 11-point Likert scale (0 = no pain; 10 = worst imaginable pain). The minimum value is 0 and maximum value is 10 with higher scores meaning a worse outcome.

    Time frame: 3 months

  2. Pain interference

    Patient-reported outcomes measures (PROMIS) 8-item pain interference measure to collect reported pain interference with various activities in the previous seven days on a scale of 1 to 5 (1 = not at all; 5 = very much); the minimum value is 8 and maximum value is 40 with higher scores meaning a worse outcome.

    Time frame: 3 months

Secondary outcomes

  1. Pain self-efficacy

    10-item Pain Self Efficacy Questionnaire (PSEQ) is employed to measure the confidence of participants to conduct activities (e.g., work, accomplish goals) despite experiencing persistent pain. Each item is rated on a 7-point Likert scale (0 = not at all confident; 6 = completely confident). Scores are summed with higher values indicating better pain self-efficacy with minimum value of 0 and maximum value of 60.

    Time frame: 3 months

  2. Pain catastrophizing scale

    13 item Pain Catastrophizing Scale (PCS) is employed to measure the degree to which one experiences catastrophic thinking related to pain with each item rated on a 5-point Likert scale (0 = not at all; 4 = all the time). Scores are summed with higher values indicating greater and less favorable levels of catastrophizing with minimum value of 0 and maximum value of 52.

    Time frame: 3 months

  3. Calm scale

    5-item scale to measure how confident one is in reaching a calm, relaxed state under certain conditions (such as, when in pain, when anxious). Each item is rated on a 7-point Likert scale (0 = not at all confident; 6 = completely confident) with a minimum value of 0 and maximum value of 30 with higher scores meaning a more favorable outcome of higher confidence.

    Time frame: 3 months

  4. Sleep disturbance

    Patient-reported outcomes measures (PROMIS) Sleep Disturbance 6-item scale that describes sleep quality and patterns. Sleep quality is rated on a scale of 5 to 1 (5 = very poor; 1 = very good) and sleep patterns on a scale of 1 to 5 (1 = not at all; 5 = very much). The minimum value is 6 and maximum value is 30 with higher scores meaning a worse outcome.

    Time frame: 3 months

  5. Depression

    Patient-reported outcomes measures (PROMIS) Depression 6-item scale measured frequency of self-reported depressive symptoms on a scale from 1 to 5 (1 = never; 5 = always). The minimum value is 6 and maximum value is 30 with higher scores meaning a worse outcome.

    Time frame: 3 months

  6. Fatigue

    Patient-reported outcomes measures (PROMIS) Fatigue 6-item scale in which the frequency of fatigue symptoms are rated on a scale from 1 to 5 (1 = never; 5 = very much). The minimum value is 6 and maximum value is 30 with higher scores meaning a worse outcome.

    Time frame: 3 months

  7. Anxiety

    Patient-reported outcomes measures (PROMIS) Anxiety 6-item scale in which the frequency of anxiety symptoms are rated on a scale from 1 to 5 (1 = never; 5 = always). The minimum value is 6 and maximum value is 30 with higher scores meaning a worse outcome.

    Time frame: 3 months

07

Study locations

1 site
08

References and documents

Publications

  • Watson H, Perez L, Bindler RJ, Filoramo M, Saunders G, Coriasco M, Hong J, Darnall BD, Wilson M. A National Randomized Controlled Trial Evaluating ASPMN Nurse-Delivered Empowered Relief(R). Pain Manag Nurs. 2026 Feb;27(1):50-60. doi: 10.1016/j.pmn.2025.10.009. Epub 2025 Nov 13. PubMed 41238484 ↗

Individual participant data

Plan to share: Yes — All outcomes data will be available to share pending appropriate data use agreements.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form, Clinical study report, Analytic code

Time frame: At study end 2031 and indefinitely.

Access criteria: Principal investigators will grant access to those with scientific interest to all collected data via the process set by Stanford Data Repository

Data sharing details ↗ · sdr.library.stanford.edu

09

Timeline

2 registry updates since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Mar 2027; primary completion for Sep 2030, 42 months later.

Of 1,297 non-industry interventional studies with no phase under Chronic Pain, half reached primary completion within 20 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 39. This study's planned 42 months is above that.

Counting every sponsor, half of 1,380 studies reached it within 20 months; a quarter within 9 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2026
First posted
Oct 7, 2026
StartEst.
Mar 1, 2027
Primary completionEst.
Sep 30, 2030
CompletionEst.
Dec 30, 2030
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Eligibility
1 inclusion criterion edited, 4 added; 1 exclusion criterion edited, 2 added
What changed in the criteria
Inclusion criteria
  • Added≥18 years of age
  • AddedPain condition with duration ≥ 3 months
  • AddedCapacity to give informed consent
  • AddedAble to read, speak, and understand English
  • Edited≥18 years of age; Pain condition with duration ≥ 3 months; Capacity to give informed consent; Able to read, speak, and understand English; Past month average pain intensity score ≥ 4/10 on a 0-10 Numerical Rating Scale
Exclusion criteria
  • AddedCognition found to be moderately or severely impaired on screening
  • AddedActive suicidality (online screening)
  • EditedCognition found to be moderately or severely impaired on screening; Active suicidality (online screening); Receipt of Empowered Relief or digital Health Education in the past 6 months
Oct 15, 2026
Primary outcomes
2 description edited
What changed in the outcomes
  • DescriptionPain intensity: how it is measured was reworded
  • DescriptionPain interference: how it is measured was reworded
Oct 15, 2026
Secondary outcomes
2 edited, 5 description edited
What changed in the outcomes
  • EditedPain catastrophizing scaleTime frame: 3 months
  • ChangedBefore Relaxation response efficacyNow Calm scaleTime frame: 3 months
  • DescriptionAnxiety: how it is measured was reworded
  • DescriptionDepression: how it is measured was reworded
  • DescriptionFatigue: how it is measured was reworded
  • DescriptionPain self-efficacy: how it is measured was reworded
  • DescriptionSleep disturbance: how it is measured was reworded
Oct 15, 2026
Registered
First appeared on the registry
Oct 7, 2026
Show all 2 updates
  1. Oct 15, 2026
    Eligibility 1 inclusion criterion edited, 4 added; 1 exclusion criterion edited, 2 added
    What changed in the criteria
    Inclusion criteria
    • Added≥18 years of age
    • AddedPain condition with duration ≥ 3 months
    • AddedCapacity to give informed consent
    • AddedAble to read, speak, and understand English
    • Edited≥18 years of age; Pain condition with duration ≥ 3 months; Capacity to give informed consent; Able to read, speak, and understand English; Past month average pain intensity score ≥ 4/10 on a 0-10 Numerical Rating Scale
    Exclusion criteria
    • AddedCognition found to be moderately or severely impaired on screening
    • AddedActive suicidality (online screening)
    • EditedCognition found to be moderately or severely impaired on screening; Active suicidality (online screening); Receipt of Empowered Relief or digital Health Education in the past 6 months
    Primary outcomes 2 description edited
    What changed in the outcomes
    • DescriptionPain intensity: how it is measured was reworded
    • DescriptionPain interference: how it is measured was reworded
    Secondary outcomes 2 edited, 5 description edited
    What changed in the outcomes
    • EditedPain catastrophizing scaleTime frame: 3 months
    • ChangedBefore Relaxation response efficacyNow Calm scaleTime frame: 3 months
    • DescriptionAnxiety: how it is measured was reworded
    • DescriptionDepression: how it is measured was reworded
    • DescriptionFatigue: how it is measured was reworded
    • DescriptionPain self-efficacy: how it is measured was reworded
    • DescriptionSleep disturbance: how it is measured was reworded
    + 2 other changes: description and arm descriptions
  2. Oct 7, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07863375
Lead sponsor
Washington State University
Responsible party
Marian Wilson (Principal Investigator, Washington State University) — Principal investigator
First posted
Oct 7, 2026
Start date
Mar 1, 2027 (estimated)
Primary completion
Sep 30, 2030 (estimated)
Completion
Dec 30, 2030 (estimated)
Last update
Oct 15, 2026

Study contacts

Marian L Wilson, PhD
Contact
marian.wilson@wsu.edu
509-358-7972
Ross J Bindler, PharmD
Contact
rossb4@wsu.edu
509-358-7987
Beth D Darnall, PhD
principal investigator · Stanford University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion